Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Immunomedics Q4 net loss increases

Immunomedics, Inc., a clinical-stage biopharmaceutical company, has reported that net loss attributable to stockholders for the fourth quarter ended June 30, 2015 was $12.4 million, or $0.13 loss per share, compared to a net loss attributable to stockholders of $11.85 million, or $0.13 loss per share, for the same quarter ended June 30, 2014.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Merck recalls Temozolomide capsules in US

Merck & Co., Inc. in conjunction with the US Consumer Product Safety Commission, or CPSC, has recalled bottles of Temodar and Temozolomide capsules with cracks in the child-resistant bottle caps.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Biogen, ALS Association and CUMC collaborate for ALS genome characterization

Biogen Inc., a biopharmaceutical company, the ALS Association and Columbia University Medical Center, or CUMC, have announced a new collaboration to understand the differences and commonalities in the amyotrophic lateral sclerosis, or ALS, disease process and how genes influence the clinical features of the disease.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Advanced Bionics receives FDA approval for new sound processors

Sonova Holding AG, a provider of hearing solutions, has announced that its subsidiary, Advanced Bionics, or AB, has received FDA approval for its new Naida CI Q90 and Q30 sound processors.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Bavarian Nordic initiates Phase I respiratory syncytial virus study

Bavarian Nordic A/S, a biopharmaceutical company, has initiated a Phase I clinical study with its MVA-BN RSV vaccine candidate against respiratory syncytial virus, or RSV, to evaluate the vaccine candidate in humans.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

GE receives FDA clearance for low dose CT lung cancer screening option

GE Healthcare, a medical technology company, has received the FDA clearance for low dose computed tomography, or CT, lung cancer screening option.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Immunomedics receives new US patent for antibody immunoconjugates

Immunomedics, Inc., a clinical-stage biopharmaceutical company, has received a new US patent for a family of antibody-SN-38 immunoconjugates with a CL2A linker.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Vernalis appoints non-executive director

Vernalis plc, a biotechnology company, has appointed Lisa Schoenberg as a non-executive director, effective September 1, 2015.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Hikma signs licensing and distribution agreement with Vitabiotics

Hikma Pharmaceuticals Plc, a manufacturer of generic and in-licensed pharmaceutical products, has signed a licensing and distribution agreement with Vitabiotics Ltd., a provider of nutraceuticals and vitamin products.

Published By MarketLine
31 Aug 2015
NewsWire
NewsWire

Photocure and BioSyent partner to distribute bladder cancer drug in Canada

Photocure ASA, a specialty pharmaceutical company, has signed a distribution agreement with BioSyent Pharma Inc. to commercialize Cysview, indicated for the treatment of bladder cancer, in Canada.

Published By MarketLine
31 Aug 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.